Liver Tumors: Benign and Malignant Overview OmpathStudy

This document provides a concise overview of both benign and malignant liver tumors. Benign tumors discussed include Cavernous Hemangioma, which is the most common and should not be biopsied due to hemorrhage risk; Focal Nodular Hyperplasia, characterized by a central stellate scar and lacking malignant potential; and Liver Cell Adenoma, which is linked to oral contraceptive use in young women and carries a significant risk of rupture. Malignant tumors are categorized into primary and secondary types. Primary malignancies include Hepatocellular Carcinoma (HCC), strongly associated with Hepatitis B and C infections, and elevated alpha-fetoprotein (AFP) levels; Cholangiocarcinoma, originating from bile ducts and notably not linked to viral hepatitis; Angiosarcoma, associated with specific toxic exposures; and Hepatoblastoma, primarily affecting children. Secondary liver malignancies (metastatic) are the most common hepatic malignancy overall, frequently originating from colon, lung, and breast cancers. Key Points Cavernous Hemangioma : Most common benign liver tumor; DO NOT biopsy due to hemorrhage risk. Focal Nodular Hyperplasia (FNH) : Characterized by a central stellate scar; no link to OCPs or malignant potential, no rupture risk. Liver Cell Adenoma : Associated with young women and OCPs; significant risk of rupture leading to intraabdominal hemorrhage. Hepatocellular Carcinoma (HCC) : Strongly linked to HBV (200x risk) and HCV; often presents with vascular invasion and AFP 1000 ng/ml. Fibrolamellar variant has a better prognosis. Cholangiocarcinoma : Bile duct origin; NOT associated with HBV/HCV, distinguishing it from HCC. Angiosarcoma : Associated with exposure to vinyl chloride, arsenic, and Thorotrast. Hepatoblastoma : Predominantly affects children. Secondary (Metastatic) Liver Tumors : Most common hepatic malignancy overall, with primary sources typically being colon, lung, and breast. Detailed Notes Benign Tumors Cavernous Hemangioma Most common benign liver tumor Incidental finding DO NOT biopsy (hemorrhage risk) Focal Nodular Hyperplasia (FNH) Central stellate scar No OCP link, no malignant potential, no rupture Liver Cell Adenoma Young women + OCPs Can rupture → intraabdominal hemorrhage Can be mistaken for HCC Regresses on stopping OCPs Malignant — Primary Hepatocellular Carcinoma (HCC) M:F = 3:1 to 8:1 Risk factors: HBV (200x risk), HCV, alcohol, aflatoxin B1, cirrhosis Vascular invasion AFP 1000 ng/ml highly suggestive Fibrolamellar variant = better prognosis Px: death 6 months-1 year Rx: surgical resection Cholangiocarcinoma Bile duct origin NOT associated with HBV/HCV Risk factors: PSC, Opisthorchis sinensis, Thorotrast AFP normal Angiosarcoma Vinyl chloride + arsenic + Thorotrast Hepatoblastoma Children Malignant — Secondary (Metastatic) Most common hepatic malignancy overall Sources: colon lung breast Key comparison: HCC Cholangiocarcinoma --- --- --- HBV/HCV Yes No AFP ↑↑ Normal Risk Cirrhosis, aflatoxin PSC, Opisthorchis Practice Questions 1. A 45-year-old female with a history of oral contraceptive use presents with acute abdominal pain and hypovolemic shock. Imaging reveals a ruptured liver mass. Which benign liver tumor is most likely given her history? → Liver Cell Adenoma 2. During a routine check-up, an incidental liver lesion is found in a 60-year-old male. Biopsy is considered, but the physician advises against it due to hemorrhage risk. What is the most likely diagnosis? → Cavernous Hemangioma 3. A patient with chronic Hepatitis B infection develops a liver mass. Serum alpha-fetoprotein (AFP) is found to be 1200 ng/ml. What is the most likely primary liver malignancy? → Hepatocellular Carcinoma (HCC) 4. A patient presents with obstructive jaundice and a mass in the bile duct. Imaging confirms a primary liver malignancy. Serology for HBV and HCV is negative, and AFP levels are normal. Which type of primary liver malignancy is suggested? → Cholangiocarcinoma 5. A biopsy of a liver lesion reveals a central stellate scar. The patient denies any history of oral contraceptive use. What is the most probable benign liver tumor? → Focal Nodular Hyperplasia (FNH) 6. What is the most common hepatic malignancy overall, and what are its three most common primary sources? → Secondary (Metastatic) liver tumors; colon lung breast 7. A child is diagnosed with a primary malignant liver tumor. What is the most likely diagnosis for a primary liver cancer in the pediatric population? → Hepatoblastoma 8. Exposure to which industrial chemicals or toxins is strongly associated with the development of Angiosarcoma of the liver? → Vinyl chloride, arsenic, and Thorotrast